These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4737643)

  • 1. Cytotoxicity of adenovirus-antibody aggregates: sensitivity to different cell strains, and inhibition by hexon antiserum and by complement.
    Kjellén L; Ankerst J
    J Virol; 1973 Jul; 12(1):25-32. PubMed ID: 4737643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity by antigen aggregation. Adenovirus neutralization assays as a model.
    Kjellén L
    Arch Gesamte Virusforsch; 1972; 39(1):1-12. PubMed ID: 4117915
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxicity of adenovirus-antibody complexes. Specificity of antibody and virus-antibody ratio at which cytotoxicity is induced.
    Kjellén L; Ankerst J
    Eur J Immunol; 1973 Feb; 3(2):78-84. PubMed ID: 4715667
    [No Abstract]   [Full Text] [Related]  

  • 4. The preparation of an antiserum to adenovirus group (hexon) antigen, to be used for immunofluorescent detection of infection with different adenoviruses.
    Spence D; Kenny G; McLure AR; MacFarlane DE; Sommerville RG
    Arch Gesamte Virusforsch; 1971; 34(4):340-5. PubMed ID: 4107477
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between the soluble antigens and the virion of adenovirus type 3. VI. Further characterization of antigenic sites available at the surface of virions.
    Norrby E; Wadell G
    Virology; 1972 Jun; 48(3):757-65. PubMed ID: 5064085
    [No Abstract]   [Full Text] [Related]  

  • 6. Abortive infection of hamster embryo cells with simian virus type 15 (SV15). I. "Helper" activity for adenovirus-associated virus type 1.
    Henry CJ; Atchison RW
    Can J Microbiol; 1972 Apr; 18(4):435-43. PubMed ID: 4623294
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and a preliminary characterization of temperature-sensitive mutants of adenovirus 12.
    Shiroki K; Irisawa J; Shimojo H
    Virology; 1972 Jul; 49(1):1-11. PubMed ID: 4556924
    [No Abstract]   [Full Text] [Related]  

  • 8. Dynamics of accumulation of capsid proteins of type 1 adenovirus (immunofluorescence and cytofluorometric data).
    Dyachenko NS; Nosach LN; Gushcha KP; Vantsak NP
    Acta Virol; 1973 Mar; 17(2):116-23. PubMed ID: 4144275
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-specific serum inhibitors are irrelevant in adenovirus haemagglutination. Brief report.
    Wigand R
    Arch Gesamte Virusforsch; 1971; 35(2):311-3. PubMed ID: 5002909
    [No Abstract]   [Full Text] [Related]  

  • 10. The purification of adenovirus neutralizing antibody: adenovirus type 5 hexon immunoadsorbent.
    Haase AT; Pereira HG
    J Immunol; 1972 Mar; 108(3):633-6. PubMed ID: 4110983
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction between HeLa cells and adenovirus type 2 virions neutralized by different antisera.
    Wohlfart CE; Svensson UK; Everitt E
    J Virol; 1985 Dec; 56(3):896-903. PubMed ID: 4068145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus neutralization--behavior of virion derived capsid components in the production of in vitro neutralizing antibody.
    Shortridge KF
    Microbios; 1972; 5(20):265-72. PubMed ID: 4673679
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies of adenovirus hexon antigens.
    Nász I; Lengyel A; Cserba I
    Arch Gesamte Virusforsch; 1972; 36(1):80-92. PubMed ID: 4622265
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological reactivity of antisera prepared against the sodium dodecyl sulfate-treated structural polypeptides of adenovirus-associated virus.
    Johnson FB; Blacklow NR; Hoggan MD
    J Virol; 1972 Jun; 9(6):1017-26. PubMed ID: 4338635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytolytic microassays and studies of SV40 tumor-specific transplantation antigen.
    Smith RW; Mora PT
    Virology; 1972 Oct; 50(1):233-46. PubMed ID: 4343110
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative comparison of techniques used to measure complement-mediated cytotoxicity of nucleated cells.
    Detrick-Hooks B; Borsos T; Rapp HJ
    J Immunol; 1975 Jan; 114(1 Pt 2):287-90. PubMed ID: 1117130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus in adenovirus type 3 conjunctivitis.
    Schmidt OW; Cooney MK; Foy HM
    Infect Immun; 1975 Jun; 11(6):1362-70. PubMed ID: 166918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mosaics of capsid components produced by cocultivation of certain human adenoviruses in vitro.
    Norrby E; Gollmar Y
    Virology; 1971 May; 44(2):383-95. PubMed ID: 4105258
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological basis of the adenovirus 8-9 cross-reaction.
    Hierholzer JC; Dowdle WR
    J Virol; 1970 Dec; 6(6):782-7. PubMed ID: 4992997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of passive hemagglutination methods for detection of antibody to viral antigen in hamsters bearing adenovirus type 12 tumors.
    Lefkowitz SS
    J Immunol; 1968 Sep; 101(3):611-6. PubMed ID: 5692103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.